# MedisourceRx, Los Alamitos, CA – FDA Inspections

Source: https://www.keypedia.com/companies/medisourcerx/9a855143-6076-4b52-a4e0-94d0d179a448

> Inspection records and compliance data for MedisourceRx in Los Alamitos, California. 4 FDA inspections on record (1 OAI), 2 Form 483s, 1 warning letter, last inspected June 10, 2025.

---

## Details

- Name: MedisourceRx
- FEI Number: 3013316698
- Facility Type: Outsourcing Facility
- Address Line 1: 10525 Humbolt St
- City: Los Alamitos
- State: California
- Zip Code: 90720
- Country Name: United States
- Address: 10525 Humbolt St, Los Alamitos, California 90720, United States
- Country: United States

## Related Documents

- [WARNING_LETTER - MedisourceRx - 2025-06-10](https://www.keypedia.com/records/warning_letter/medisourcerx/1fbda26f-82db-460c-9e19-19e6a0a63187) — source: FDA, date: June 10, 2025
- [483 - MedisourceRx - 2025-06-10](https://www.keypedia.com/records/483/medisourcerx/a62ac39b-abb0-4a75-b0c8-d8990528dd22) — source: FDA, date: June 10, 2025
- [FDA Inspection 1272492 - MedisourceRx - 2025-06-10](https://www.keypedia.com/records/fda_inspections/medisourcerx/5e1c7664-e512-4a49-832f-44a69404210a) — classification: Official Action Indicated (OAI), source: FDA, date: June 10, 2025
- FDA Inspection 1191700 - MedisourceRx - 2022-11-04 — classification: No Action Indicated (NAI), source: FDA, date: November 4, 2022
- [483 - MedisourceRx - 2020-10-22](https://www.keypedia.com/records/483/medisourcerx/a1e1ffa0-3bb0-4b18-a86d-b3dda15cef25) — source: FDA, date: October 22, 2020
- [FDA Inspection 1131719 - MedisourceRx - 2020-10-22](https://www.keypedia.com/records/fda_inspections/medisourcerx/a41be081-b03d-43cf-bdf8-7b6507777311) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 22, 2020
- [483 - MedisourceRx - 2018-09-27](https://www.keypedia.com/records/483/medisourcerx/37374085-c2ea-4dec-8f59-bc0e62b5afa1) — source: FDA, date: September 27, 2018
- [FDA Inspection 1067011 - MedisourceRx - 2018-09-27](https://www.keypedia.com/records/fda_inspections/medisourcerx/edce067b-34b5-461a-893a-58fbf6a61073) — source: FDA, date: September 27, 2018

## Related Companies

- [Mitali Wadekar, M.D.](https://www.keypedia.com/companies/mitali-wadekar-md/d8f9c290-6f40-45e6-8f79-14f7ef472f2e)
- [Cidara Therapeutics, Inc.](https://www.keypedia.com/companies/cidara-therapeutics-inc/0939c114-6a06-4c82-a75a-7cafd388cc6b)
- [FibroGen Incorporated](https://www.keypedia.com/companies/fibrogen-incorporated/f2c76cea-1b73-450e-a90a-b12a9e39baa8)
- [BioMarin Pharmaceutical Inc.](https://www.keypedia.com/companies/biomarin-pharmaceutical-inc/73126e34-fd3f-451a-beef-466225ecadc2)
- [Michael E. Gottschalk, M.D.](https://www.keypedia.com/companies/michael-e-gottschalk-md/3b333bcd-e981-4c8f-8be5-55323f07ad73)
- [Kenneth N. Sokolski, M.D.](https://www.keypedia.com/companies/kenneth-n-sokolski-md/951dd56a-55d7-4dbb-8f81-95415f2b17c7)
- [Norman Lepor](https://www.keypedia.com/companies/norman-lepor/8b067220-ffbe-4541-9b4f-4f6a558ece58)
- [Sohan L. Dua, M.D](https://www.keypedia.com/companies/sohan-l-dua-md/24a62291-2dfe-41ab-805a-0efd7b50ec29)
- [RINATI SKIN LLC](https://www.keypedia.com/companies/rinati-skin-llc/24f7a238-790e-445f-9e2f-aa6291813b34)
- [Mark Savant, M.D.](https://www.keypedia.com/companies/mark-savant-md/4733594e-2101-4145-a989-432bb8ede00a)

## Related Officers

- [Pharmaceutical investigator](https://www.keypedia.com/people/bryan-a-galvez/d1e52abc-5b56-4ffb-af22-90e6733fb73a)
- [Professor](https://www.keypedia.com/people/liming-zhang/6c93b721-8725-4d87-8a42-254f3de5e49d)
- [Consumer Safety Officer](https://www.keypedia.com/people/sangeeta-m-khurana/bed4533f-a9aa-47c5-9e0b-f20ad36461aa)
